Mobilization For Health: National Prevention Partnership Awards

 

The National Vaccine Program Office (NVPO) collaborates with federal partners to provide strategic direction for the coordination of the vaccine and immunization enterprise for the National Vaccine Plan (NVP) implementation http://www.hhs.gov/nvpo/vacc_plan/2010%20Plan/nationalvaccineplan.pdf NVPO is looking to partner with an institution or organization to conduct research, monitoring or outcomes definition research related to vaccine safety. The areas of research are specifically, but not limited to, predicting the safety profile of new vaccines during the early development stage, developing or modifying existing vaccines to improve their safety, conducting applied research that will have a direct impact on the current vaccine safety monitoring system, conducting research that will improve the safety profile of currently marketed vaccines, conducting research that will achieve consensus definitions of vaccine safety outcomes that could be utilized to collect consensus data in clinical research conducted globally.

Deleted 03/27/2024 (Archived.) 93.311 Office of The Assistant Secretary, Department of Health and Human Services B - Project Grants Not applicable. Department of Health and Human Services, Office of the Assistant Secretary for Health, National Vaccine Program Office, Section 1702(a) [42 U.S.C. 300u-1(a)] and Section 1703(a) and (c) [42 U.S.C. 300u-2(a) and (c)] of the Public Health Service Act, as amended Public (including city, county, regional, and State government) organizations and private nonprofit entities. All children, women (including pregnant women), and adults, including those underserved and minority populations in the US. A nonprofit private entity must provide evidence of its nonprofit status. Preapplication coordination is not applicable. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. To apply, access the announcement thru www.grants.gov. Enter the CFDA# and follow the website instructions. Applications submitted after the deadlines will not be accepted for review. The submission deadline will not be extended. Applications which do not conform to the requirements of the grant announcement will not be accepted for review and will be returned to the applicant. Applications may only be submitted electronically via www.grants.gov. Any applications submitted via any other means of electronic communication, including facsimile or electronic mail, will not be accepted for review. Applications will be screened upon receipt. Those that are judged to be ineligible will be returned without comment. Accepted applications will be reviewed for technical merit in accordance with PHS policies. Applications will be evaluated by a technical review panel composed of experts. Final funding decisions will be determined by the OASH OWH, OMH, NVPO Office Director; taken into consideration are the recommendations of the review panel; program needs, stated preferences; geographic location; and recommendations of DHHS Regional Health Administrators. All applicants are notified in writing of actions taken on their applications. A Notice of Award is issued for those applications that are approved and funded. Contact the headquarters or regional location, as appropriate for application deadlines From 90 to 120 days. Not applicable. Renewal awards may be approved pending availability of funding, and evidence of satisfactory progress and compliance. Please see FOA The assistance can be applied to improving vaccine safety knowledge, improving the monitoring of adverse events following immunization, or improving the way vaccine safety data are collected and analyzed in clinical trials. Examples of applicability are predicting the safety profile of new vaccines during the early development stage, developing or modifying existing vaccines to improve their safety, conducting applied research that will have a direct impact on the current vaccine safety monitoring system, conducting research that will improve the safety profile of currently marketed vaccines, conducting research that will achieve consensus definitions of vaccine safety outcomes that could be utilized to collect consensus data in clinical research conducted globally. Funds are restricted from being used for the following: alterations or renovations; construction; fund-raising activities; job training; political education and lobbying; vocational rehabilitation. Performance Reports: A final performance report is due 90 days following the end of the project period. Not applicable. HHS and the Comptroller General of the United States or any of their authorized representatives, shall have the right of access to any books, documents, papers, or other records of a grantee, sub-grantee, contractor, or subcontractor, which are pertinent to the HHS grant, in order to make audits, examinations, excerpts and transcripts. In accordance with 45 CFR, Part 74.53 and 45 CFR, Part 92, grantees are required to maintain grant accounting records 3 years after the end of a project period. If any litigation, claim, negotiation, audit or other action involving the records has been started before the expiration of the 3-year period, the records shall be retained until completion of the action and resolution of all issues which arise from it, or until the end of the regular 3-year period, whichever is later. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. CATEGORY A ($50,000 to $75,000) Funding (1year, including a 12 month option to extend to 24 months) CATEGORY B (not to exceed $500,000) Funding (3 year project period) Annual increments by budget period for Project A and B. Grants may not exceed 3 years (subject to the availability of funds). Payments will be made either on a monthly cash request basis or under the Electronic Transfer System. Necessary instructions for the appropriate type of payment will be issued at the time an award is made. Method of awarding/releasing assistance: Letter. Regional Offices will be identified separately Roscoe Brunson
Tower Building Suite 550, 1101 Wootton Parkway
Rockville, MD 20852 US
roscoe.brunson@hhs.gov
Phone: 240-453-8822 http://www.hhs.gov/ash/public_health/indexph.html 75-0120-0-1-551 (Project Grants) FY 18$0.00; FY 19 est $0.00; FY 20 est $0.00; FY 17 Estimate Not Available FY 16$2,428,998.00; - Program ended in 2017 Program ended June, 2018 Not applicable. Not applicable.